Replies to post #53759 on NorthWest Biotherapeutics Inc (NWBO)

[austinmediainc]

Austin

Your post is not justified. You cannot imply that the reference to Checkpoint Inhibitors disappeared, never to be seen again.

At NWBO's recent presentation at Phacilitate on Jan 26 the slide presentation stated:-

'Patients treated with DCVax-Direct exhibit both de novo or increased T cell responses and de novo or increased PD-L1 expression.'

And:-

'DCVax-Direct may help increase percentage of patients responding to
checkpoint inhibitors'

So the door is still widely open.

I guess the door is still wide open for a number of things, but that doesn't mean they're going to happen. Linda mentioned that they were looking into a combo trial, it was done as a teaser. Just like they continually said they were in talks to partner DcVax Prostate, it was in every presentation they gave.....until it wasn't. It disappeared and was never talked about again. This is something that keeps repeating itself with NWBO Management. They throw something out to tease people and then when it doesn't transpire it's never talked about again. I have to admit, it's been a good strategy.